Naume, Bjørn
Oslo University Hospital · University of Oslo
6 papers on CoChatORCID 0000-0002-6811-9476
Most cited papers
- Verified
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
Røssevold, A. H., Andresen, N. K., Bjerre, C. A., Gilje, B., Jakobsen, E. H., Raj, S. X., Falk, R. S., Russnes, H. G., Jahr, T., Mathiesen, R. R., et al. (2022) · Nature Medicine
Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies
Cited by 89
- Verified
Fatigue During and After Breast Cancer Therapy—A Prospective Study
Reinertsen, K. V., Engebraaten, O., Loge, J. H., Cvancarova, M., Naume, B., Wist, E., Edvardsen, H., Wille, E., Bjøro, T., & Kiserud, C. E. (2017) · Journal of Pain and Symptom Management
Cancer survivorship and careCancer-related cognitive impairment studies
Cited by 71
- Verified
Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
Krüger, K., Silwal-Pandit, L., Wik, E., Straume, O., Stefansson, I. M., Borgen, E., Garred, Ø., Naume, B., Engebraaten, O., & Akslen, L. A. (2021) · Scientific Reports
Breast Cancer Treatment StudiesAngiogenesis and VEGF in Cancer
Cited by 32
- Verified
ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
Kyte, J. A., Røssevold, A., Falk, R. S., & Naume, B. (2020) · Journal of Translational Medicine
Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies
Cited by 28
- Verified
Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer
Ullern, A., Holm, K., Røssevold, A. H., Andresen, N. K., Bang, C., Lingjærde, O. C., Naume, B., Hov, J. R., & Kyte, J. A. (2025) · Molecular Oncology
Gut microbiota and healthCancer Immunotherapy and Biomarkers
Cited by 25
- Verified
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer
von der Lippe Gythfeldt, H., Lien, T., Tekpli, X., Silwal‐Pandit, L., Borgen, E., Garred, Ø., Skjerven, H., Schlichting, E., Lundgren, S., Wist, E., et al. (2020) · International Journal of Cancer
Breast Cancer Treatment StudiesAngiogenesis and VEGF in Cancer
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free